Of mice and microflora: Considerations for genetically engineered mice

Veterinary Pathology

Volumn 49, Issue 1, 2012, Pages 44-63

  Treuting, P M ^a   Clifford, C B ^b   Sellers, R S ^c   Brayton, C F ^d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b CHARLES RIVER LABORATORIES   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

animal; animals; bacterial infections and mycoses; genetically modified; infectious disease; mice; models; parasitic diseases; pathology; review; specific pathogen free; transgenic; viral diseases

Indexed keywords

ANIMAL; ANIMAL DISEASE; COMMUNICABLE DISEASE; DISEASE MODEL; GENETIC ENGINEERING; GENETICS; GERMFREE ANIMAL; HUMAN; MICROBIOLOGY; MOUSE; PARASITOLOGY; PHENOTYPE; REVIEW; RODENT DISEASE; TRANSGENIC MOUSE;

ANIMALS; COMMUNICABLE DISEASES; DISEASE MODELS, ANIMAL; GENETIC ENGINEERING; HUMANS; MICE; MICE, TRANSGENIC; PHENOTYPE; RODENT DISEASES; SPECIFIC PATHOGEN-FREE ORGANISMS;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS;

EID: 84855384502     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985811431446     Document Type: Review

References (123)

1. Ammann CG,Messer RJ,Varvel K, et al.Effects of acute and chronic murine norovirus infections on immune responses and recovery from Friend retrovirus infection.J Virol. 2009;83:13037-13041.
2. Baker DG.Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.Clin Microbiol Rev. 1998;11:231-266.
3. Baker DGNatural Pathogens of Laboratory Animals. Washington, DC: ASM Press; 2003:.
4. Barthold SW."Muromics": genomics from the perspective of the laboratory mouse.Comp Med. 2002;52:206-223.
5. Barthold SW,Smith AMouse Hepatitis Virus. Fox JG BSDavisson MTNewcomer CE, ed. Burlington: Academic Press; 2007:141-178.
6. Berg DJ,Davidson N,Kuhn R, et al.Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) Th1-like responses.J Clin Invest. 1996;98:1010-1020.
7. Berry D,Xi C,Raskin L.Microbial ecology of drinking water distribution systems.Curr Opin Biotechnol. 2006;17:297-302.
8. Besselsen DG,Romero MJ,Wagner AM, et al.Identification of novel murine parvovirus strains by epidemiological analysis of naturally infected mice.J Gen Virol. 2006;87 (pt 6): 1543-1556.
9. Buonocore S,Ahern PP,Uhlig HH, et al.Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology.Nature. 2010;464:1371-1375.
10. Burr HN,Lipman NS,White JR, et al.Strategies to prevent, treat, and provoke Corynebacterium-associated hyperkeratosis in athymic nude mice.J Am Assoc Lab Anim Sci. 2011;50:378-388.
11. Cadwell K,Patel KK,Maloney NS, et al.Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine.Cell. 2010;141:1135-1145.
12. Cardiff RD,Rosner A,Hogarth MA, et al.Validation: the new challenge for pathology.Toxicol Pathol. 2004;32 (suppl 1): 31-39.
13. Carlson J,Garg R,Compton SR, et al.Poliomyelitis in SCID mice following injection of basement membrane matrix contaminated with lactate dehydrogenase-elevating virus.JAALAS. 2008;47:PS35.
14. Carty AJ.Opportunistic infections of mice and rats: Jacoby and Lindsey revisited.ILAR J. 2008;49:272-276.
15. Caviness GF,Thigpen JE,Locklear J, et al.Incidence of mycoplasma contaminants in cell cultures: detection and growth on trypticase soy agar containing 5% sheep blood.J Am Assoc Lab Anim Sci. 2008;47:106-106.
16. Chabe M,Aliouat-Denis CM,Delhaes L, et al.Pneumocystis: from a doubtful unique entity to a group of highly diversified fungal species.FEMS Yeast Res. 2011;11:2-17.
17. Chen W,Mills JW,Harmsen AG.Development and resolution of Pneumocystis carinii pneumonia in severe combined immunodeficient mice: a morphological study of host inflammatory responses.Int J Exp Pathol. 1992;73:709-720.
18. Clarke MC,Taylor RJ,Hall GA, et al.The occurrence in mice of facial and mandibular abscesses associated with Staphylococcus aureus.Lab Anim. 1978;12:121-123.
19. Clifford CB,Walton BJ,Reed TH, et al.Hyperkeratosis in athymic nude mice caused by a coryneform bacterium: microbiology, transmission, clinical signs, and pathology.Lab Anim Sci. 1995;45:131-139.
20. Collins LV,Kristian SA,Weidenmaier C, et al.Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice.J Infect Dis. 2002;186:214-219.
21. Compton SR,Riley LK.Detection of infectious agents in laboratory rodents: traditional and molecular techniques.Comp Med. 2001;51:113-119.
22. Compton SR,Ball-Goodrich LJ,Zeiss CJ, et al.Pathogenesis of mouse hepatitis virus infection in gamma interferon-deficient mice is modulated by co-infection with Helicobacter hepaticus.Comp Med. 2003;53:197-206.
23. Compton SR,Ball-Goodrich LJ,Johnson LK, et al.Pathogenesis of enterotropic mouse hepatitis virus in immunocompetent and immunodeficient mice.Comp Med. 2004;54:681-689.
24. Compton SR,Ball-Goodrich LJ,Paturzo FX, et al.Transmission of enterotropic mouse hepatitis virus from immunocompetent and immunodeficient mice.Comp Med. 2004;54:29-35.
25. Compton SR,Paturzo FX,Macy JD.Effect of murine norovirus infection on mouse parvovirus infection.J Am Assoc Lab Anim Sci. 2010;49:11-21.
26. Crane LR,Tagle LC,Palutke WA.Outbreak of Pseudomonas paucimobilis in an intensive care facility.JAMA. 1981;246:985-987.
27. Cray C,Besselsen DG,Hart JL, et al.Quantitation of acute phase proteins and protein electrophoresis in monitoring the acute inflammatory process in experimentally and naturally infected mice.Comp Med. 2010;60:263-271.
28. Cromeans TL,Kahler AM,Hill VR.Inactivation of adenoviruses, enteroviruses, and murine norovirus in water by free chlorine and monochloramine.Appl Environ Microbiol. 2010;76:1028-1033.
29. Deloris Alexander A,Orcutt R,Henry J, et al.Quantitative PCR assays for mouse enteric flora reveal strain-dependent differences in composition that are influenced by the microenvironment.Mamm Genome. 2006;17:1093-1104.
30. Dervisoglu E,Meric M,Kalender B, et al.Sphingomonas paucimobilis peritonitis: a case report and literature review.Perit Dial Int. 2008;28:547-550.
31. Dewhirst FE,Chien CC,Paster BJ, et al.Phylogeny of the defined murine microbiota: altered Schaedler flora.Appl Environ Microbiol. 1999;65:3287-3292.
32. Donohoe Dallas R,Garge N,Zhang X, et al.The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon.Cell Metab. 2011;13:517-526.
33. Donovan JC,Mayo JG,Rice JM, et al.Helicobacter-associated hepatitis of mice.Lab Anim Sci. 1993;43:403.
34. Drexler HG,Uphoff CC,Dirks WG, et al.Mix-ups and mycoplasma: the enemies within.Leuk Res. 2002;26:329-333.
35. Erdman S,Fox JG,Dangler CA, et al.Typhlocolitis in NF-kappa B-deficient mice.J Immunol. 2001;166:1443-1447.
36. Flynn RJ,Baker DG. American College of Laboratory Animal Medicine. Flynn's Parasites of Laboratory Animals. 2nd ed. Ames, IO: Blackwell; 2007.Ames, IO: Blackwell; 2007:.
37. Fox JGThe Mouse in Biomedical Research. 2nd ed. Amsterdam; Boston: Elsevier; 2007.Amsterdam; Boston: Elsevier; 2007:.
38. Fox JG.Helicobacter bilis: bacterial provocateur orchestrates host immune responses to commensal flora in a model of inflammatory bowel disease.Gut. 2007;56:898-900.
39. Fox JG,Ge Z,Whary MT, et al.Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer.Mucosal Immunol. 2011;4:22-30.
40. France MP,Muir D.An outbreak of pulmonary mycosis in respiratory burst-deficient (gp91(phox-/-))mice with concurrent acidophilic macrophage pneumonia.J Comp Pathol. 2000;123:190-194.
41. Franklin CL.Microbial considerations in genetically engineered mouse research.ILAR J. 2006;47:141-155.
42. Fredrickson JK,Balkwill DL,Romine MF, et al.Ecology, physiology, and phylogeny of deep subsurface Sphingomonas sp.J Ind Microbiol Biotechnol. 1999;23:273-283.
43. Ge Z,Schauer DB,Fox JG.In vivo virulence properties of bacterial cytolethal-distending toxin.Cell Microbiol. 2008;10:1599-1607.
44. Godfrey VThe Mouse in Biomedical Research. 2, 2nd ed. Amsterdamand Boston: Elsevier; 2007: 507-515.Fox JG, ed. Amsterdam and Boston: Elsevier; 2007:507-515.
45. Gozalo AS,Hoffmann VJ,Brinster LR, et al.Spontaneous Staphylococcus xylosus infection in mice deficient in NADPH oxidase and comparison with other laboratory mouse strains.J Am Assoc Lab Anim Sci. 2010;49:480-486.
46. Harrington LE,Hatton RD,Mangan PR, et al.Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.Nat Immunol. 2005;6:1123-1132.
47. Hasnain SZ,Thornton DJ,Grencis RK.Changes in the mucosal barrier during acute and chronic Trichuris muris infection.Parasite Immunol. 2011;33:45-55.
48. Henderson KS.Murine norovirus, a recently discovered and highly prevalent viral agent of mice.Lab Anim (NY). 2008;37:314-320.
49. Hensley SE,Pinto AK,Hickman HD, et al.Murine norovirus infection has no significant effect on adaptive immunity to vaccinia virus or influenza a virus.J Virol. 2009;83:7357-7360.
50. Homberger FR,Zhang L,Barthold SW.Prevalence of enterotropic and polytropic mouse hepatitis virus in enzootically infected mouse colonies.Lab Anim Sci. 1998;48:50-54.
51. Hsueh PR,Teng LJ,Yang PC, et al.Nosocomial infections caused by Sphingomonas paucimobilis: clinical features and microbiological characteristics.Clin Infect Dis. 1998;26:676-681.
52. Infectious Diseases of Mice and Rats. Washington, DC: National Academy Press; 1991:.
53. Iwatsuki K,Yamasaki O,Morizane S, et al.Staphylococcal cutaneous infections: invasion, evasion and aggression.J Dermatol Sci. 2006;42:203-214.
54. Jacoby RO,Ball-Goodrich LJ,Besselsen DG, et al.Rodent parvovirus infections.Lab Anim Sci. 1996;46:370-380.
55. Jacoby RO,Ball-Goodrich LThe Mouse in Biomedical Research. 2, 2nd ed. Burlington, MA: Academic Press; 2007: 93-103.Fox JGBarthold SWDavisson MT, ed. Burlington, MA: Academic Press; 2007:93-103.
56. Jacoby RO,Fox JG,Davisson MLaboratory Animal Medicine. 2nd ed. Amsterdam and New York: Academic Press; 2002: 35-120. Fox JGAnderson LCLoew FMQuimby FM, ed. Amsterdam and New York: Academic Press; 2002:35-120.
57. Karst SM,Wobus CE,Lay M, et al.STAT1-dependent innate immunity to a Norwalk-like virus.Science. 2003;299:1575-1578.
58. Kilic A,Senses Z,Kurekci AE, et al.Nosocomial outbreak of Sphingomonas paucimobilis bacteremia in a hemato/oncology unit.Jpn J Infect Dis. 2007;60:394-396.
59. Kilkenny C,Browne W,Cuthill I, et alJ Pharmacol Pharmacother. 2010:94-9.
60. Klocke J,Barcia RN,Heimer S, et al.Spontaneous bacterial keratitis in CD36 knockout mice.Invest Ophthalmol Vis Sci. 2011;52:256-263.
61. Kullberg MC,Jankovic D,Feng CG, et al.IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis.J Exp Med. 2006;203:2485-2494.
62. Kurtzman CP,Robnett CJ,Ward JM, et al.Multigene phylogenetic analysis of pathogenic candida species in the Kazachstania (Arxiozyma) telluris complex and description of their ascosporic states as Kazachstania bovina sp. nov., K. heterogenica sp. nov., K. pintolopesii sp. nov., and K. slooffiae sp. nov.J Clin Microbiol. 2005;43:101-111.
63. Labelle P,Hahn NE,Fraser JK, et al.Mousepox detected in a research facility: case report and failure of mouse antibody production testing to identify ectromelia virus in contaminated mouse serum.Comp Med. 2009;59:180-186.
64. Layland LE,Mages J,Loddenkemper C, et al.Pronounced phenotype in activated regulatory T cells during a chronic helminth infection.J Immunol. 2010;184:713-724.
65. Lencioni KC,Seamons A,Treuting PM, et al.Murine norovirus: an intercurrent variable in a mouse model of bacteria-induced inflammatory bowel disease.Comp Med. 2008;58:522-533.
66. Lim MY,Kim JM,Lee JE, et al.Characterization of ozone disinfection of murine norovirus.Appl Environ Microbiol. 2010;76:1120-1124.
67. Lipman NS,Henderson K,Shek W.False negative results using RT-PCR for detection of lactate dehydrogenase-elevating virus in a tumor cell line.Comp Med. 2000;50:255-256.
68. Lipman NS,Perkins S,Nguyen H, et al.Mousepox resulting from use of ectromelia virus-contaminated, imported mouse serum.Comp Med. 2000;50:426-435.
69. Lipman NS,Homberger FR.Rodent quality assurance testing: use of sentinel animal systems.Lab Anim (NY). 2003;32:36-43.
70. Livingston RS,Riley LK.Diagnostic testing of mouse and rat colonies for infectious agents.Lab Anim (NY). 2003;32:44-51.
71. Liyanage NP,Manthey KC,Dassanayake RP, et al.Helicobacter hepaticus cytolethal distending toxin causes cell death in intestinal epithelial cells via mitochondrial apoptotic pathway.Helicobacter. 2010;15:98-107.
72. Macy JD,Paturzo FX,Ball-Goodrich LJ, et al.A PCR-based strategy for detection of mouse parvovirus.J Am Assoc Lab Anim Sci. 2009;48:263-267.
73. Macy JD,Cameron GA,Smith PC, et al.Detection and control of mouse parvovirus.J Am Assoc Lab Anim Sci. 2011;50:516-522.
74. Maggio-Price L,Shows D,Waggie K, et al.Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice.Am J Pathol. 2002;160:739-751.
75. Maggio-Price L,Treuting P,Zeng W, et al.Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice.Cancer Res. 2006;66:828-838.
76. Mahler M,Kohl W.A serological survey to evaluate contemporary prevalence of viral agents and Mycoplasma pulmonis in laboratory mice and rats in Western Europe.Lab Anim (NY). 2009;38:161-165.
77. Mark R,Buller L,Fenner FThe Mouse in Biomedical Research. 2, 2nd ed. Burlington, MA: Academic Press; 2007: 67-92.Fox JGBarthold SWDavisson MT, ed. Burlington, MA: Academic Press; 2007:67-92.
78. Maronpot RR,Boorman GA,Gaul BWPathology of the Mouse. 1st ed. Vienna, IL: Cache River Press; 1999.Vienna, IL: Cache River Press; 1999:.
79. Matharu KS,Mizoguchi E,Cotoner CA, et al.Toll-like receptor 4-mediated regulation of spontaneous Helicobacter-dependent colitis in IL-10-deficient mice.Gastroenterology. 2009;137:1380 e1381-1390 1383.
80. Mathijs E,Denayer S,Palmeira L, et al.Novel norovirus recombinants and of GII.4 sub-lineages associated with outbreaks between 2006 and 2010 in Belgium.Virol J. 2011;8:310.
81. Matsuya Y,Kusano T,Endo S, et al.Reduced tumorigenicity by addition in vitro of Sendai virus.Eur J Cancer. 1978;14:837-850.
82. Mayeux P,Dupepe L,Dunn K, et al.Massive fungal contamination in animal care facilities traced to bedding supply.Appl Environ Microbiol. 1995;61:2297-2301.
83. McCartney SA,Thackray LB,Gitlin L, et al.MDA-5 Recognition of a murine norovirus.PLoS Pathog. 4:2008 e1000108.
84. McKisic MD,Paturzo FX,Smith AL.Mouse parvovirus infection potentiates rejection of tumor allografts and modulates T cell effector functions.Transplantation. 1996;61:292-299.
85. McKisic MD,Macy JD,Delano ML, et al.Mouse parvovirus infection potentiates allogeneic skin graft rejection and induces syngeneic graft rejection.Transplantation. 1998;65:1436-1446.
86. Meier TR,Maute CJ,Cadillac JM, et al.Quantification, distribution, and possible source of bacterial biofilm in mouse automated watering systems.J Am Assoc Lab Anim Sci. 2008;47:63-70.
87. Moehler MH,Zeidler M,Wilsberg V, et al.Parvovirus H-1-induced tumor cell death enhances human immune response in vitro via increased phagocytosis, maturation, and cross-presentation by dendritic cells.Hum Gene Ther. 2005;16:996-1005.
88. Mook DM,Benjamin KA.Use of selamectin and moxidectin in the treatment of mouse fur mites.J Am Assoc Lab Anim Sci. 2008;47:20-24.
89. Muller B,Klemm U,Mas Marques A, et al.Genetic diversity and recombination of murine noroviruses in immunocompromised mice.Arch Virol. 2007;152:1709-1719.
90. Mumphrey SM,Changotra H,Moore TN, et al.Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses.J Virol. 2007;81:3251-3263.
91. Myles MH,Dieckgraefe BK,Criley JM, et al.Characterization of cecal gene expression in a differentially susceptible mouse model of bacterial-induced inflammatory bowel disease.Inflamm Bowel Dis. 2007;13:822-836.
92. Nagamine CM,Sohn JJ,Rickman BH, et al.Helicobacter hepaticus infection promotes colon tumorigenesis in the BALB/c-Rag2(-/-) Apc(Min/+) mouse.Infect Immun. 2008;76:2758-2766.
93. Nakai N,Kawaguchi C,Nawa K, et al.Detection and elimination of contaminating microorganisms in transplantable tumors and cell lines.Exp Anim. 2000;49:309-313.
94. Naugler S.L.,Myles M. H.,Bauer B. A., et al.Reduced fecundity and death associated with parvovirus infection in B-lymphocyte deficient mice.Contemp Top Lab Anim Sci. 2001;40:66.
95. Nicklas W,Staut M,Benner A.Prevalence and biochemical properties of V factor-dependent Pasteurellaceae from rodents.Zentralbl Bakteriol. 1993;279:114-124.
96. Paik J,Fierce Y,Drivdahl R, et al.Effects of murine norovirus infection on a mouse model of diet-induced obesity and insulin resistance.Comp Med. 2010;60:189-195.
97. Paik J,Fierce Y,Mai P-O, et al.Murine norovirus increases atherosclerotic lesion size and macrophages in Ldlr-/- mice.Comp Med. 2011;61:330-338.
98. Percy DH,Barthold SWPathology of Laboratory Rodents and Rabbits. 3rd ed. Ames, IA: Blackwell; 2007: 3-124.Percy DHBarthold SW, ed. Ames, IA: Blackwell; 2007:3-124.
99. Perdue KA,Copeland MK,Karjala Z, et al.Suboptimal ability of dirty-bedding sentinels to detect Spironucleus muris in a colony of mice with genetic manipulations of the adaptive immune system.J Am Assoc Lab Anim Sci. 2008;47:10-17.
100. Peterson NC.From bench to cageside: risk assessment for rodent pathogen contamination of cells and biologics.ILAR J. 2008;49:310-315.
101. Pritchett-Corning KR,Cosentino J, et al.Contemporary prevalence of infectious agents in laboratory mice and rats.Lab Anim. 2009;43:165-173.
102. Rahija R.The Mouse in Biomedical Research. 2nd ed. Amsterdam and Boston: Elsevier; 2007: 217-233. Fox JG, ed. Amsterdam and Boston: Elsevier; 2007:217-233.
103. Rao VP,Poutahidis T,Ge Z, et al.Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice.Cancer Res. 2006;66:7395-7400.
104. Rao VP,Poutahidis T,Fox JG, et al.Breast cancer: should gastrointestinal bacteria be on our radar screen?.Cancer Res. 2007;67:847-850.
105. Rehg JE,Toth LA.Rodent quarantine programs: purpose, principles, and practice.Lab Anim Sci. 1998;48:438-447.
106. Rehg JE,Blackman MA,Toth LA.Persistent transmission of mouse hepatitis virus by transgenic mice.Comp Med. 2001;51:369-374.
107. Ricart Arbona RJ,Lipman NS,Wolf FR.Treatment and eradication of murine fur mites: III. Treatment of a large mouse colony with ivermectin-compounded feed.J Am Assoc Lab Anim Sci. 2010;49:633-637.
108. Rogers AB,Fox JG.Inflammation and cancer, I: rodent models of infectious gastrointestinal and liver cancer.Am J Physiol Gastrointest Liver Physiol. 2004;286:G361-G366.
109. Roseto A,Guillemin MC,Chehimi J, et al.Elimination of mycoplasma, bacteria, and fungi contaminants of hybridoma cultures by intraperitoneal passage in the mouse.Hybridoma. 1984;3:297-300.
110. Scanziani E,Gobbi A,Crippa L, et al.Hyperkeratosis-associated coryneform infection in severe combined immunodeficient mice.Lab Anim. 1998;32:330-336.
111. Shomer NH,Dangler CA,Schrenzel MD, et al.Helicobacter bilis-induced inflammatory bowel disease in scid mice with defined flora.Infect Immun. 1997;65:4858-4864.
112. Smith KA,Hochweller K,Hammerling GJ, et al.Chronic helminth infection promotes immune regulation in vivo through dominance of CD11cloCD103- dendritic cells.J Immunol. 2011;186:7098-7109.
113. Spor A,Koren O,Ley R.Unravelling the effects of the environment and host genotype on the gut microbiome.Nat Rev Micro. 2011;9:279-290.
114. Stecher B,Hardt WD.The role of microbiota in infectious disease.Trends Microbiol. 2008;16:107-114.
115. Story J,Thigpen J,Meshaw K, et al.Mycoplasma arginini associated with swollen joints in: severe combined immunodeficient mice implanted with tumor cells.J Am Assoc Lab Anim Sci. 2008;47:107.
116. Taylor NS,Xu S,Nambiar P, et al.Enterohepatic Helicobacter species are prevalent in mice from commercial and academic institutions in Asia, Europe, and North America.J Clin Microbiol. 2007;45:2166-2172.
117. Tomczak MF,Erdman SE,Poutahidis T, et al.NF-kappa B is required within the innate immune system to inhibit microflora-induced colitis and expression of IL-12 p40.J Immunol. 2003;171:1484-1492.
118. Turnbaugh PJ,Ley RE,Mahowald MA, et al.An obesity-associated gut microbiome with increased capacity for energy harvest.Nature. 2006;444:1027-1131.
119. Turnbaugh PJ,Ley RE,Hamady M, et al.The Human Microbiome Project.Nature. 2007;449:804-810.
120. Waggie KSManual of Microbiologic Monitoring of Laboratory Animals. 2nd ed. Bethesda, MD: US Dept of Health and Human Services, Public Health Service, National Institutes of Health, National Center for Research Resources; 1994.Bethesda, MD: US Dept of Health and Human Services, Public Health Service, National Institutes of Health, National Center for Research Resources; 1994:.
121. Ward JM,Wobus CE,Thackray LB, et al.Pathology of immunodeficient mice with naturally occurring murine norovirus infection.Toxicol Pathol. 2006;34:708-715.
122. Whary MT,Fox JG.Detection, eradication, and research implications of Helicobacter infections in laboratory rodents.Lab Anim (NY). 2006;35:25 30-27 26.
123. Wobus CE,Karst SM,Thackray LB, et al.Replication of norovirus in cell culture reveals a tropism for dendritic cells and macrophages.PLoS Biol. 2004;2:e432.